JP2009533338A5 - - Google Patents

Download PDF

Info

Publication number
JP2009533338A5
JP2009533338A5 JP2009504144A JP2009504144A JP2009533338A5 JP 2009533338 A5 JP2009533338 A5 JP 2009533338A5 JP 2009504144 A JP2009504144 A JP 2009504144A JP 2009504144 A JP2009504144 A JP 2009504144A JP 2009533338 A5 JP2009533338 A5 JP 2009533338A5
Authority
JP
Japan
Prior art keywords
styrylquinazoline
patent document
compounds
rastinejad
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009504144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009533338A (ja
Filing date
Publication date
Priority claimed from NZ546477A external-priority patent/NZ546477A/en
Application filed filed Critical
Publication of JP2009533338A publication Critical patent/JP2009533338A/ja
Publication of JP2009533338A5 publication Critical patent/JP2009533338A5/ja
Pending legal-status Critical Current

Links

JP2009504144A 2006-04-07 2007-04-04 置換環縮合アジンおよび癌治療におけるそれらの使用 Pending JP2009533338A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ546477A NZ546477A (en) 2006-04-07 2006-04-07 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy
PCT/NZ2007/000077 WO2007117161A1 (en) 2006-04-07 2007-04-04 Substituted ring fused azines and their use in cancer therapy

Publications (2)

Publication Number Publication Date
JP2009533338A JP2009533338A (ja) 2009-09-17
JP2009533338A5 true JP2009533338A5 (https=) 2010-05-06

Family

ID=38581368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504144A Pending JP2009533338A (ja) 2006-04-07 2007-04-04 置換環縮合アジンおよび癌治療におけるそれらの使用

Country Status (8)

Country Link
US (1) US20090318479A1 (https=)
EP (1) EP2004637A4 (https=)
JP (1) JP2009533338A (https=)
CN (1) CN101460490A (https=)
AU (1) AU2007235751A1 (https=)
CA (1) CA2648323A1 (https=)
NZ (1) NZ546477A (https=)
WO (1) WO2007117161A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046207A1 (en) * 2010-10-08 2012-04-12 Paraco Technology Limited Anti-parasitic substituted ring fused azine compounds
US8710064B2 (en) * 2011-10-20 2014-04-29 China Medical University 2-aryl-4-quinazolinones and their pharmaceutical compositions
CN104350056A (zh) 2012-06-07 2015-02-11 霍夫曼-拉罗奇有限公司 端锚聚合酶的吡咯并嘧啶酮和吡咯并吡啶酮抑制剂
CN104540830A (zh) 2012-06-07 2015-04-22 霍夫曼-拉罗奇有限公司 端锚聚合酶的吡唑并嘧啶酮和吡唑并吡啶酮抑制剂
WO2014143609A1 (en) 2013-03-11 2014-09-18 Bristol-Myers Squibb Company Isoquinolines as potassium ion channel inhibitors
AU2014353006B2 (en) 2013-11-20 2019-04-04 Signalchem Life Sciences Corp. Quinazoline derivatives as TAM family kinase inhibitors
RU2684396C2 (ru) * 2014-10-29 2019-04-09 Донг-А Ст Ко., Лтд. Новые соединения пиридопиримидинона для модулирования каталитической активности гистонлизиндеметилаз (KDMS)
US20170057955A1 (en) * 2015-08-26 2017-03-02 Dong-A Socio Holdings Co., Ltd. Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs)
CN107721982B (zh) * 2017-10-16 2019-12-03 中山大学 一种抗肥胖症化合物及其制备方法和应用
CN110483394A (zh) * 2019-09-02 2019-11-22 广东工业大学 一种化合物的应用
CN113072543B (zh) * 2020-01-03 2022-07-22 南方医科大学 一种2-芳杂环基喹唑啉酮类化合物及其制备方法和用途
US20230339866A1 (en) * 2020-02-04 2023-10-26 TroBio Therapeutics Pty Ltd Quinazoline compounds and the use thereof in the treatment of cancer
JP2023542921A (ja) 2020-09-21 2023-10-12 ランドス バイオファーマ インコーポレイテッド Nlrx1リガンド
CN114044769B (zh) * 2021-11-25 2023-12-12 中山大学 一种β-吲哚喹唑啉酮衍生物及其制备方法和应用
CN117247374B (zh) * 2022-06-10 2026-03-17 四川科伦博泰生物医药股份有限公司 一种bcl-xl抑制剂及其制药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897432A (en) * 1971-04-21 1975-07-29 Merck & Co Inc Substituted benzimidazole derivatives
CN1329493A (zh) * 1998-12-02 2002-01-02 辉瑞产品公司 恢复p53家族蛋白质的构象稳定性的方法和组合物
EP1088818B1 (en) * 1999-10-01 2004-11-03 F. Hoffmann-La Roche Ag Quinolin-4-yl derivatives
KR100774855B1 (ko) * 2000-04-27 2007-11-08 아스텔라스세이야쿠 가부시키가이샤 축합 헤테로아릴 유도체
WO2002062767A1 (en) * 2001-02-07 2002-08-15 Sumitomo Pharmaceuticals Company, Limited Novel quinazoline derivatives

Similar Documents

Publication Publication Date Title
JP2009533338A5 (https=)
CY2020012I2 (el) Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων
JP2011506530A5 (https=)
DK1853310T3 (da) Anti-Abeta-antistofpræparat
JP2009544651A5 (https=)
JP2008515616A5 (https=)
JP2008501714A5 (https=)
JP2011508438A5 (https=)
JP2007525988A5 (https=)
JP2012502876A5 (https=)
JP2011519271A5 (https=)
TW200715632A (en) Inorganic compounds
DE602005002110D1 (de) Polymerisierbare fluorierte Verbindung, Herstellungsverfahren, Polymer, Resistzusammenstellung und Strukturierungsverfahren
JP2012049345A5 (https=)
DE602006008312D1 (de) Mesostrukturiertes material mit hohem aluminiumgehalt
JP2009263366A5 (https=)
IS7341A (is) Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar
JP2009504909A5 (https=)
NO20054895L (no) Fremgangsmate for fremstilling av karbonmaterialer
JP2009532412A5 (https=)
JP2009055850A5 (https=)
JP2008517002A5 (https=)
JP2007105705A5 (https=)
NL1031392A1 (nl) Granulair vast wasdeeltje.
JP2009215399A5 (https=)